Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT06575010
Effective and safe control of pain after shoulder surgery is an important component of the post-surgical process. Patients who are comfortable in the early period after surgery are more satisfied with their experience and are better able to participate in rehabilitation exercises during their stay in the hospital. As surgeons and health care systems in the United States find themselves in the middle of an opioid epidemic, it is necessary to discover different options to provide patients pain relief that are both effective and safe in an effort to decrease the amount of pain medication used.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 4
Philadelphia, Pennsylvania, 19107, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20 mL Liposomal bupivacaine (Exparel) will be given in the shoulder block prior to surgery
0.75% bupivacaine will be given in the shoulder block prior to surgery
10 mg Dexamethasone will be given in the shoulder block prior to surgery
Time frame: 14 days
Participants will be asked to record the amount of medication they take to control pain after surgery
Time frame: 14 days
This will be measured by providing participants the visual analog scale (VAS) questionnaire as well as a postoperative pain recording diary to complete after surgery
Rothman Institute Orthopaedics
Other
Single-Shot Liposomal Bupivacaine vs. Liposomal Bupivacaine Combined With Dexamethasone Following Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06139666
Neurologic Manifestations, Opioid Use
Camden, New Jersey, United States
View Trial DetailsNCT07689448
Agnosia, Interscalene Blocks
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07375927
Arthralgia, Joint Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06505135
Arthritis, Chondrocalcinosis
Sønderborg, Danmark, Denmark
View Trial Details